Siga gets requests for smallpox drug in Europe as monkeypox spreads – Reuters.com

Siga gets requests for smallpox drug in Europe as monkeypox spreads – Reuters.com

May 19 (Reuters) – Siga Technologies Inc (SIGA.O) has received requests for the use of its smallpox drug to treat monkeypox, its chief executive officer told Reuters on Thursday, as cases spread in parts of Europe.
There had been no deliveries yet but the company was "well-positioned" in terms of supply, CEO Phil Gomez said.
The drug, approved to treat smallpox in the United States and the family of orthopoxvirus that includes monkeypox and cowpox in the EU, has been in government stockpiles as part of the pandemic response.
"As you can imagine with the outbreak in Europe, we have received requests and we are responding to those as we can. We’re engaged with our colleagues in Europe about the best way to support that response," Gomez said, without disclosing details on the requests.
Monkeypox cases have now been reported or are suspected in Britain, Portugal, Spain and the United States. The virus causes fever symptoms as well as a distinctive bumpy rash. read more
The disease, first identified in monkeys, typically spreads through close contact and largely occurs in west and central Africa. read more
New York-based Siga’s shares were up 19% on Thursday, along with shares of other smallpox vaccine and drug developers.
Copenhagen-based drugmaker Bavarian Nordic (BAVA.CO) on Thursday said it had secured a contract with an undisclosed European country to supply its smallpox vaccine, Imvanex, in response to the outbreak.
Our Standards: The Thomson Reuters Trust Principles.
Sign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.
Subscribe to our newsletter to get all the news you need to start your day.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved

source


Leave a Reply

Your email address will not be published.